Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Cardiology
/ New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
New Era in the Lipid Lowering Treatment with PCSK9 Inhibitors (Evolocumab and Alirocumab) in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia
Complimentary
Categories:
Activity Type
,
Online Activity
,
Cardiology
,
Credit Type
,
ANCC
,
CME
,
Endocrinology
,
Family Medicine
,
Internal Medicine
,
Profession
,
Nurse
,
Nurse Practitioner
,
Physician
,
Physician Assistant
Related products
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures
Read more
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more
New Prospects in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
Scroll To Top